Skip to main content

Surgical Optimization as Part of a Multidisciplinary Approach to 3D Cell Culture Chemosensitivity in HGG Patients (Session 5 of 6)

High Grade Glioma (HGG) Functional Precision Medicine—A Six Webinar Series

Virtual 60-minute webinar featuring expert discussion of real world HGG patient cases.

SESSION 5 of 6

For this fifth installment of a six-webinar series, join us to hear how Dr. Ryan of the Virginia Mason Medical Center is utilizing surgical optimization as part of a multidisciplinary approach to 3D Cell Culture Chemosensitivity in HGG Patients.

High-grade glioma (HGG) patients have extremely poor prognoses. Limited diagnostic tools to accurately predict treatment responses leads to challenges in selecting effective therapeutic options. This interactive discussion will feature real world clinical cases presented by Dr. Roby Ryan of the Virginia Mason Medical Center, where a new functional precision oncology assay was used to direct therapy. Attendees will have the opportunity to participate in an interactive Q&A with Dr. Ryan.

This Functional Precision Medicine Webinar Series is powered by OncoLens. On a single, secure platform, OncoLens data science, informatics and advanced collaboration tools provide a first of a kind platform for targeted treatment planning and confident clinical decision making.


Roby Ryan, MD

Co-Director of Neuro-Oncology
Virginia Mason Medical Center

June 5, 2024 | 2:00 PM EDT

High Grade Glioma (HGG) Functional Precision Medicine Webinar Series


Eric Perreault


Other Sessions